APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiotherapy

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. The principle is to use high-energy ionizing radiation (such as X-rays, gamma rays, high-energy electrons or heavy particles) produced by Medical Electron Linear Accelerator or radioactive nuclei to control or destroy malignant cells. Radiation therapy can cure some cancers that are only present in specific parts of the body, and can also be used as adjuvant therapy to prevent the recurrence of tumors after surgery to remove the primary malignant tumor (for example, to treat early-stage breast cancer). Ionizing radiation can damage the DNA of cancer tissue, causing its cells to die. In order to leave normal tissues (such as skin or organs, through which radiation must pass to treat tumors) unaffected, the radiation beam will illuminate the cancerous tissue from several specific angles. Tumors produce a much greater absorbed dose than surrounding healthy tissue. In addition to the tumor itself, the radiation field may also include draining lymph nodes if they are clinically or radiologically associated with malignancy or are considered to be at risk for subclinical malignant spread. Either way, the cells are killed by destroying the genetic material (DNA) of malignant cells. Cancer cells whose DNA is damaged and cannot be repaired will stop dividing or die. When damaged cells die, they are broken down and eliminated by the body. Radiation therapy does not kill cancer cells immediately; the level of DNA damage that causes cancer cell death requires days or weeks of treatment.

Radiotherapy equipment is an important treatment tool in current tumor treatment, including Medical Electron Linear Accelerator, Gamma Knife, Cyberknife, TomoTherapy, proton and heavy ion equipment, etc., among which the global The most commonly used one is the Medical Electron Linear Accelerator. Medical Electron Linear Accelerator is usually used clinically to define and plan the treatment target area based on CT images, and to give the target area a certain dose of uniform irradiation. In radiotherapy, target volume delineation, measurement prescription design, and radiotherapy plan design can all directly affect the effect of radiotherapy. However, because delineation and design work rely on technicians and radiotherapy doctors, there are many uncertainties. The positioning error is one of the important factors affecting the accuracy of radiotherapy. In addition, there are many factors that cause positioning and imaging differences during the entire radiotherapy process for patients, making it difficult for the entire radiotherapy effect to fully achieve the intended goal.

Proton and heavy particle therapy are another modality. Proton therapy, also known as "proton knife", uses neutral uncharged particles (such as neutrons) or charged particles (such as protons) to enter the human body and release energy to kill tumor cells. Currently, protons and Carbon ions. The entire treatment process can provide powerful irradiation to tumor lesions while avoiding irradiation of normal tissues to maximize the curative effect. Proton radiotherapy is currently the most cutting-edge cancer treatment technology. In the world of cancer treatment, heavy ions are another word for carbon ions (C6+). It is said that the dose concentration of heavy ions is better than that of protons, and the killing effect on cancer cells is 2-3 times that of protons. This effect can reduce the number of fractions and shorten the treatment cycle. Heavy ion therapy is also expected to be effective in treating cancers that are resistant to conventional X-ray radiation therapy, such as sarcomas and adenocarcinomas, locally advanced cancers, and deep-seated cancers. Broadly speaking, a heavy ion beam includes any beam of particles heavier than electrons. In heavy ion radiation therapy in Japan, the term "heavy ion beam" refers to a beam of nuclei (heavy ions) of any atom heavier than helium (He) or with an atomic number greater than helium. In Japan, carbon ion beams have been used for heavy ion beam therapy for nearly 20 years. Therefore, "heavy ion beam" currently refers to "carbon ion beam".

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For Radiotherapy, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable radiotherapy performance?

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Market Analysis & Forecast

Global Radiotherapy Market Analysis and Forecast 2026-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchRadiotherapy Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiotherapy Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Radiotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiotherapy Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiotherapy Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. The principle is to use high-energy ionizing radiation (such as X-rays, gamma rays, high-energy electrons or heavy particles) produced by Medical Electron Linear Accelerator or radioactive nuclei to control or destroy malignant cells. Radiation therapy can cure some cancers that are only present in specific parts of the body, and can also be used as adjuvant therapy to prevent the recurrence of tumors after surgery to remove the primary malignant tumor (for example, to treat early-stage breast cancer). Ionizing radiation can damage the DNA of cancer tissue, causing its cells to die. In order to leave normal tissues (such as skin or organs, through which radiation must pass to treat tumors) unaffected, the radiation beam will illuminate the cancerous tissue from several specific angles. Tumors produce a much greater absorbed dose than surrounding healthy tissue. In addition to the tumor itself, the radiation field may also include draining lymph nodes if they are clinically or radiologically associated with malignancy or are considered to be at risk for subclinical malignant spread. Either way, the cells are killed by destroying the genetic material (DNA) of malignant cells. Cancer cells whose DNA is damaged and cannot be repaired will stop dividing or die. When damaged cells die, they are broken down and eliminated by the body. Radiation therapy does not kill cancer cells immediately; the level of DNA damage that causes cancer cell death requires days or weeks of treatment.

Radiotherapy equipment is an important treatment tool in current tumor treatment, including Medical Electron Linear Accelerator, Gamma Knife, Cyberknife, TomoTherapy, proton and heavy ion equipment, etc., among which the global The most commonly used one is the Medical Electron Linear Accelerator. Medical Electron Linear Accelerator is usually used clinically to define and plan the treatment target area based on CT images, and to give the target area a certain dose of uniform irradiation. In radiotherapy, target volume delineation, measurement prescription design, and radiotherapy plan design can all directly affect the effect of radiotherapy. However, because delineation and design work rely on technicians and radiotherapy doctors, there are many uncertainties. The positioning error is one of the important factors affecting the accuracy of radiotherapy. In addition, there are many factors that cause positioning and imaging differences during the entire radiotherapy process for patients, making it difficult for the entire radiotherapy effect to fully achieve the intended goal.

Proton and heavy particle therapy are another modality. Proton therapy, also known as "proton knife", uses neutral uncharged particles (such as neutrons) or charged particles (such as protons) to enter the human body and release energy to kill tumor cells. Currently, protons and Carbon ions. The entire treatment process can provide powerful irradiation to tumor lesions while avoiding irradiation of normal tissues to maximize the curative effect. Proton radiotherapy is currently the most cutting-edge cancer treatment technology. In the world of cancer treatment, heavy ions are another word for carbon ions (C6+). It is said that the dose concentration of heavy ions is better than that of protons, and the killing effect on cancer cells is 2-3 times that of protons. This effect can reduce the number of fractions and shorten the treatment cycle. Heavy ion therapy is also expected to be effective in treating cancers that are resistant to conventional X-ray radiation therapy, such as sarcomas and adenocarcinomas, locally advanced cancers, and deep-seated cancers. Broadly speaking, a heavy ion beam includes any beam of particles heavier than electrons. In heavy ion radiation therapy in Japan, the term "heavy ion beam" refers to a beam of nuclei (heavy ions) of any atom heavier than helium (He) or with an atomic number greater than helium. In Japan, carbon ion beams have been used for heavy ion beam therapy for nearly 20 years. Therefore, "heavy ion beam" currently refers to "carbon ion beam".

Read the full market overview

The global Radiotherapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Radiotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Radiotherapy include Varian Medical Systems (Siemens Healthineers), Elekta, Hitachi, IBA(Ion Beam Applications S.A), Accuray, Mevion Medical Systems, Shanghai United Imaging Healthcare, Shinva Medical Instrument and Toshiba, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Radiotherapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radiotherapy, also provides the sales of main regions and countries. Of the upcoming market potential for Radiotherapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiotherapy sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Radiotherapy sales, projected growth trends, production technology, application and end-user industry.

Radiotherapy Segment by Company

Varian Medical Systems (Siemens Healthineers)

Elekta

Hitachi

IBA(Ion Beam Applications S.A)

Accuray

Mevion Medical Systems

Shanghai United Imaging Healthcare

Shinva Medical Instrument

Toshiba

Neusoft Medical Systems

Chengdu Linike Medical

Sumitomo Heavy Industries

Jiangsu Haiming Medical Equipment

SinoPower Accelerator

Radiotherapy Segment by Type

External Beam Radiotherapy

Internal Beam Radiotherapy

Radiotherapy Segment by Application

Lung Cancer

Breast Cancer

Rectal Cancer

Prostate Cancer

Stomach Cancer

Liver Cancer

Cervical Cancer

Lung Cancer

Head and Neck Cancer

Other

Radiotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Radiotherapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Radiotherapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiotherapy sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiotherapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. External Beam Radiotherapy Major Manufacturers Table 3. Internal Beam Radiotherapy Major Manufacturers Table 4. Global Radiotherapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Lung Cancer Major Manufacturers Table 6. Breast Cancer Major Manufacturers Table 7. Rectal Cancer Major Manufacturers Table 8. Prostate Cancer Major Manufacturers Table 9. Stomach Cancer Major Manufacturers Table 10. Liver Cancer Major Manufacturers Table 11. Cervical Cancer Major Manufacturers Table 12. Lung Cancer Major Manufacturers Table 13. Head and Neck Cancer Major Manufacturers Table 14. Other Major Manufacturers Table 15. Radiotherapy Industry Trends Table 16. Radiotherapy Industry Drivers Table 17. Radiotherapy Industry Opportunities and Challenges Table 18. Radiotherapy Industry Restraints Table 19. Global Radiotherapy Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Radiotherapy Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Radiotherapy Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Radiotherapy Revenue Market Share by Region (2021-2026) Table 23. Global Radiotherapy Revenue Market Share by Region (2027-2032) Table 24. Global Radiotherapy Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 25. Global Radiotherapy Sales by Region (2021-2026) & (Units) Table 26. Global Radiotherapy Sales by Region (2027-2032) & (Units) Table 27. Global Radiotherapy Sales Market Share by Region (2021-2026) Table 28. Global Radiotherapy Sales Market Share by Region (2027-2032) Table 29. Global Radiotherapy Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Radiotherapy Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Radiotherapy Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Radiotherapy Sales Market Share by Manufacturers (2021-2026) Table 33. Global Radiotherapy Sales Price ($M/Unit) of Manufacturers (2021-2026) Table 34. Global Radiotherapy Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Radiotherapy Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Radiotherapy Manufacturers, Product Type & Application Table 37. Global Radiotherapy Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Radiotherapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Radiotherapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Radiotherapy Revenue Market Share by Type (2021-2026) Table 44. Global Radiotherapy Revenue Market Share by Type (2027-2032) Table 45. Global Radiotherapy Sales by Type 2021 VS 2025 VS 2032 (Units) Table 46. Global Radiotherapy Sales by Type (2021-2026) & (Units) Table 47. Global Radiotherapy Sales by Type (2027-2032) & (Units) Table 48. Global Radiotherapy Sales Market Share by Type (2021-2026) Table 49. Global Radiotherapy Sales Market Share by Type (2027-2032) Table 50. Global Radiotherapy Price by Type (2021-2026) & ($M/Unit) Table 51. Global Radiotherapy Price by Type (2027-2032) & ($M/Unit) Table 52. Global Radiotherapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Radiotherapy Revenue Market Share by Application (2021-2026) Table 56. Global Radiotherapy Revenue Market Share by Application (2027-2032) Table 57. Global Radiotherapy Sales by Application 2021 VS 2025 VS 2032 (Units) Table 58. Global Radiotherapy Sales by Application (2021-2026) & (Units) Table 59. Global Radiotherapy Sales by Application (2027-2032) & (Units) Table 60. Global Radiotherapy Sales Market Share by Application (2021-2026) Table 61. Global Radiotherapy Sales Market Share by Application (2027-2032) Table 62. Global Radiotherapy Price by Application (2021-2026) & ($M/Unit) Table 63. Global Radiotherapy Price by Application (2027-2032) & ($M/Unit) Table 64. Varian Medical Systems (Siemens Healthineers) Company Information Table 65. Varian Medical Systems (Siemens Healthineers) Business Overview Table 66. Varian Medical Systems (Siemens Healthineers) Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 67. Varian Medical Systems (Siemens Healthineers) Radiotherapy Product Portfolio Table 68. Varian Medical Systems (Siemens Healthineers) Recent Development Table 69. Elekta Company Information Table 70. Elekta Business Overview Table 71. Elekta Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 72. Elekta Radiotherapy Product Portfolio Table 73. Elekta Recent Development Table 74. Hitachi Company Information Table 75. Hitachi Business Overview Table 76. Hitachi Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 77. Hitachi Radiotherapy Product Portfolio Table 78. Hitachi Recent Development Table 79. IBA(Ion Beam Applications S.A) Company Information Table 80. IBA(Ion Beam Applications S.A) Business Overview Table 81. IBA(Ion Beam Applications S.A) Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 82. IBA(Ion Beam Applications S.A) Radiotherapy Product Portfolio Table 83. IBA(Ion Beam Applications S.A) Recent Development Table 84. Accuray Company Information Table 85. Accuray Business Overview Table 86. Accuray Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 87. Accuray Radiotherapy Product Portfolio Table 88. Accuray Recent Development Table 89. Mevion Medical Systems Company Information Table 90. Mevion Medical Systems Business Overview Table 91. Mevion Medical Systems Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 92. Mevion Medical Systems Radiotherapy Product Portfolio Table 93. Mevion Medical Systems Recent Development Table 94. Shanghai United Imaging Healthcare Company Information Table 95. Shanghai United Imaging Healthcare Business Overview Table 96. Shanghai United Imaging Healthcare Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 97. Shanghai United Imaging Healthcare Radiotherapy Product Portfolio Table 98. Shanghai United Imaging Healthcare Recent Development Table 99. Shinva Medical Instrument Company Information Table 100. Shinva Medical Instrument Business Overview Table 101. Shinva Medical Instrument Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 102. Shinva Medical Instrument Radiotherapy Product Portfolio Table 103. Shinva Medical Instrument Recent Development Table 104. Toshiba Company Information Table 105. Toshiba Business Overview Table 106. Toshiba Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 107. Toshiba Radiotherapy Product Portfolio Table 108. Toshiba Recent Development Table 109. Neusoft Medical Systems Company Information Table 110. Neusoft Medical Systems Business Overview Table 111. Neusoft Medical Systems Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 112. Neusoft Medical Systems Radiotherapy Product Portfolio Table 113. Neusoft Medical Systems Recent Development Table 114. Chengdu Linike Medical Company Information Table 115. Chengdu Linike Medical Business Overview Table 116. Chengdu Linike Medical Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 117. Chengdu Linike Medical Radiotherapy Product Portfolio Table 118. Chengdu Linike Medical Recent Development Table 119. Sumitomo Heavy Industries Company Information Table 120. Sumitomo Heavy Industries Business Overview Table 121. Sumitomo Heavy Industries Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 122. Sumitomo Heavy Industries Radiotherapy Product Portfolio Table 123. Sumitomo Heavy Industries Recent Development Table 124. Jiangsu Haiming Medical Equipment Company Information Table 125. Jiangsu Haiming Medical Equipment Business Overview Table 126. Jiangsu Haiming Medical Equipment Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 127. Jiangsu Haiming Medical Equipment Radiotherapy Product Portfolio Table 128. Jiangsu Haiming Medical Equipment Recent Development Table 129. SinoPower Accelerator Company Information Table 130. SinoPower Accelerator Business Overview Table 131. SinoPower Accelerator Radiotherapy Sales (Units), Revenue (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 132. SinoPower Accelerator Radiotherapy Product Portfolio Table 133. SinoPower Accelerator Recent Development Table 134. North America Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 135. North America Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 136. North America Radiotherapy Sales by Type (2021-2026) & (Units) Table 137. North America Radiotherapy Sales by Type (2027-2032) & (Units) Table 138. North America Radiotherapy Sales Price by Type (2021-2026) & ($M/Unit) Table 139. North America Radiotherapy Sales Price by Type (2027-2032) & ($M/Unit) Table 140. North America Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 141. North America Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 142. North America Radiotherapy Sales by Application (2021-2026) & (Units) Table 143. North America Radiotherapy Sales by Application (2027-2032) & (Units) Table 144. North America Radiotherapy Sales Price by Application (2021-2026) & ($M/Unit) Table 145. North America Radiotherapy Sales Price by Application (2027-2032) & ($M/Unit) Table 146. North America Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America Radiotherapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. North America Radiotherapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. North America Radiotherapy Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 150. North America Radiotherapy Sales by Country (2021-2026) & (Units) Table 151. North America Radiotherapy Sales by Country (2027-2032) & (Units) Table 152. North America Radiotherapy Sales Price by Country (2021-2026) & ($M/Unit) Table 153. North America Radiotherapy Sales Price by Country (2027-2032) & ($M/Unit) Table 154. United States Radiotherapy Revenue (2021-2032) & (US$ Million) Table 155. Canada Radiotherapy Revenue (2021-2032) & (US$ Million) Table 156. Mexico Radiotherapy Revenue (2021-2032) & (US$ Million) Table 157. Europe Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 158. Europe Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 159. Europe Radiotherapy Sales by Type (2021-2026) & (Units) Table 160. Europe Radiotherapy Sales by Type (2027-2032) & (Units) Table 161. Europe Radiotherapy Sales Price by Type (2021-2026) & ($M/Unit) Table 162. Europe Radiotherapy Sales Price by Type (2027-2032) & ($M/Unit) Table 163. Europe Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 164. Europe Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 165. Europe Radiotherapy Sales by Application (2021-2026) & (Units) Table 166. Europe Radiotherapy Sales by Application (2027-2032) & (Units) Table 167. Europe Radiotherapy Sales Price by Application (2021-2026) & ($M/Unit) Table 168. Europe Radiotherapy Sales Price by Application (2027-2032) & ($M/Unit) Table 169. Europe Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe Radiotherapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Europe Radiotherapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Europe Radiotherapy Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 173. Europe Radiotherapy Sales by Country (2021-2026) & (Units) Table 174. Europe Radiotherapy Sales by Country (2027-2032) & (Units) Table 175. Europe Radiotherapy Sales Price by Country (2021-2026) & ($M/Unit) Table 176. Europe Radiotherapy Sales Price by Country (2027-2032) & ($M/Unit) Table 177. Germany Radiotherapy Revenue (2021-2032) & (US$ Million) Table 178. France Radiotherapy Revenue (2021-2032) & (US$ Million) Table 179. U.K. Radiotherapy Revenue (2021-2032) & (US$ Million) Table 180. Italy Radiotherapy Revenue (2021-2032) & (US$ Million) Table 181. Russia Radiotherapy Revenue (2021-2032) & (US$ Million) Table 182. Spain Radiotherapy Revenue (2021-2032) & (US$ Million) Table 183. Netherlands Radiotherapy Revenue (2021-2032) & (US$ Million) Table 184. Switzerland Radiotherapy Revenue (2021-2032) & (US$ Million) Table 185. Sweden Radiotherapy Revenue (2021-2032) & (US$ Million) Table 186. Poland Radiotherapy Revenue (2021-2032) & (US$ Million) Table 187. China Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 188. China Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 189. China Radiotherapy Sales by Type (2021-2026) & (Units) Table 190. China Radiotherapy Sales by Type (2027-2032) & (Units) Table 191. China Radiotherapy Sales Price by Type (2021-2026) & ($M/Unit) Table 192. China Radiotherapy Sales Price by Type (2027-2032) & ($M/Unit) Table 193. China Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 194. China Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 195. China Radiotherapy Sales by Application (2021-2026) & (Units) Table 196. China Radiotherapy Sales by Application (2027-2032) & (Units) Table 197. China Radiotherapy Sales Price by Application (2021-2026) & ($M/Unit) Table 198. China Radiotherapy Sales Price by Application (2027-2032) & ($M/Unit) Table 199. Asia Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 200. Asia Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 201. Asia Radiotherapy Sales by Type (2021-2026) & (Units) Table 202. Asia Radiotherapy Sales by Type (2027-2032) & (Units) Table 203. Asia Radiotherapy Sales Price by Type (2021-2026) & ($M/Unit) Table 204. Asia Radiotherapy Sales Price by Type (2027-2032) & ($M/Unit) Table 205. Asia Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 206. Asia Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 207. Asia Radiotherapy Sales by Application (2021-2026) & (Units) Table 208. Asia Radiotherapy Sales by Application (2027-2032) & (Units) Table 209. Asia Radiotherapy Sales Price by Application (2021-2026) & ($M/Unit) Table 210. Asia Radiotherapy Sales Price by Application (2027-2032) & ($M/Unit) Table 211. Asia Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. Asia Radiotherapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. Asia Radiotherapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. Asia Radiotherapy Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 215. Asia Radiotherapy Sales by Country (2021-2026) & (Units) Table 216. Asia Radiotherapy Sales by Country (2027-2032) & (Units) Table 217. Asia Radiotherapy Sales Price by Country (2021-2026) & ($M/Unit) Table 218. Asia Radiotherapy Sales Price by Country (2027-2032) & ($M/Unit) Table 219. Japan Radiotherapy Revenue (2021-2032) & (US$ Million) Table 220. South Korea Radiotherapy Revenue (2021-2032) & (US$ Million) Table 221. India Radiotherapy Revenue (2021-2032) & (US$ Million) Table 222. Australia Radiotherapy Revenue (2021-2032) & (US$ Million) Table 223. Taiwan Radiotherapy Revenue (2021-2032) & (US$ Million) Table 224. Southeast Asia Radiotherapy Revenue (2021-2032) & (US$ Million) Table 225. SAMEA Radiotherapy Revenue by Type (2021-2026) & (US$ Million) Table 226. SAMEA Radiotherapy Revenue by Type (2027-2032) & (US$ Million) Table 227. SAMEA Radiotherapy Sales by Type (2021-2026) & (Units) Table 228. SAMEA Radiotherapy Sales by Type (2027-2032) & (Units) Table 229. SAMEA Radiotherapy Sales Price by Type (2021-2026) & ($M/Unit) Table 230. SAMEA Radiotherapy Sales Price by Type (2027-2032) & ($M/Unit) Table 231. SAMEA Radiotherapy Revenue by Application (2021-2026) & (US$ Million) Table 232. SAMEA Radiotherapy Revenue by Application (2027-2032) & (US$ Million) Table 233. SAMEA Radiotherapy Sales by Application (2021-2026) & (Units) Table 234. SAMEA Radiotherapy Sales by Application (2027-2032) & (Units) Table 235. SAMEA Radiotherapy Sales Price by Application (2021-2026) & ($M/Unit) Table 236. SAMEA Radiotherapy Sales Price by Application (2027-2032) & ($M/Unit) Table 237. SAMEA Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 238. SAMEA Radiotherapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 239. SAMEA Radiotherapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 240. SAMEA Radiotherapy Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 241. SAMEA Radiotherapy Sales by Country (2021-2026) & (Units) Table 242. SAMEA Radiotherapy Sales by Country (2027-2032) & (Units) Table 243. SAMEA Radiotherapy Sales Price by Country (2021-2026) & ($M/Unit) Table 244. SAMEA Radiotherapy Sales Price by Country (2027-2032) & ($M/Unit) Table 245. Brazil Radiotherapy Revenue (2021-2032) & (US$ Million) Table 246. Argentina Radiotherapy Revenue (2021-2032) & (US$ Million) Table 247. Chile Radiotherapy Revenue (2021-2032) & (US$ Million) Table 248. Colombia Radiotherapy Revenue (2021-2032) & (US$ Million) Table 249. Peru Radiotherapy Revenue (2021-2032) & (US$ Million) Table 250. Saudi Arabia Radiotherapy Revenue (2021-2032) & (US$ Million) Table 251. Israel Radiotherapy Revenue (2021-2032) & (US$ Million) Table 252. UAE Radiotherapy Revenue (2021-2032) & (US$ Million) Table 253. Turkey Radiotherapy Revenue (2021-2032) & (US$ Million) Table 254. Iran Radiotherapy Revenue (2021-2032) & (US$ Million) Table 255. Egypt Radiotherapy Revenue (2021-2032) & (US$ Million) Table 256. Key Raw Materials Table 257. Raw Materials Key Suppliers Table 258. Radiotherapy Distributors List Table 259. Radiotherapy Customers List Table 260. Research Programs/Design for This Report Table 261. Authors List of This Report Table 262. Secondary Sources Table 263. Primary Sources List of Figures Figure 1. Radiotherapy Image Figure 2. Global Radiotherapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiotherapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. External Beam Radiotherapy Image Figure 5. Internal Beam Radiotherapy Image Figure 6. Global Radiotherapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Radiotherapy Market Size Share 2021 VS 2025 VS 2032 Figure 8. Lung Cancer Image Figure 9. Breast Cancer Image Figure 10. Rectal Cancer Image Figure 11. Prostate Cancer Image Figure 12. Stomach Cancer Image Figure 13. Liver Cancer Image Figure 14. Cervical Cancer Image Figure 15. Lung Cancer Image Figure 16. Head and Neck Cancer Image Figure 17. Other Image Figure 18. Global Radiotherapy Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Radiotherapy Revenue (2021-2032) & (US$ Million) Figure 20. Global Radiotherapy Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Radiotherapy Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Radiotherapy Revenue Market Share by Region (2021-2032) Figure 23. Global Radiotherapy Sales (2021-2032) & (Units) Figure 24. Global Radiotherapy Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 25. Global Radiotherapy Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Radiotherapy Sales YoY (2021-2032) & (Units) Figure 27. Europe Radiotherapy Sales YoY (2021-2032) & (Units) Figure 28. China Radiotherapy Sales YoY (2021-2032) & (Units) Figure 29. Asia (Excluding China) Radiotherapy Sales YoY (2021-2032) & (Units) Figure 30. South America, Middle East and Africa Radiotherapy Sales YoY (2021-2032) & (Units) Figure 31. Global Radiotherapy Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Radiotherapy Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Radiotherapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Radiotherapy Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Radiotherapy Revenue Market Share by Type (2021-2032) Figure 37. Global Radiotherapy Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 38. Global Radiotherapy Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Radiotherapy Sales Market Share by Type (2021-2032) Figure 40. Global Radiotherapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Radiotherapy Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Radiotherapy Revenue Market Share by Application (2021-2032) Figure 43. Global Radiotherapy Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 44. Global Radiotherapy Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Radiotherapy Sales Market Share by Application (2021-2032) Figure 46. North America Radiotherapy Revenue Share by Type (2021-2032) Figure 47. North America Radiotherapy Sales Share by Type (2021-2032) Figure 48. North America Radiotherapy Revenue Share by Application (2021-2032) Figure 49. North America Radiotherapy Sales Share by Application (2021-2032) Figure 50. North America Radiotherapy Revenue Share by Country (2021-2032) Figure 51. North America Radiotherapy Sales Share by Country (2021-2032) Figure 52. Europe Radiotherapy Revenue Share by Type (2021-2032) Figure 53. Europe Radiotherapy Sales Share by Type (2021-2032) Figure 54. Europe Radiotherapy Revenue Share by Application (2021-2032) Figure 55. Europe Radiotherapy Sales Share by Application (2021-2032) Figure 56. Europe Radiotherapy Revenue Share by Country (2021-2032) Figure 57. Europe Radiotherapy Sales Share by Country (2021-2032) Figure 58. China Radiotherapy Revenue Share by Type (2021-2032) Figure 59. China Radiotherapy Sales Share by Type (2021-2032) Figure 60. China Radiotherapy Revenue Share by Application (2021-2032) Figure 61. China Radiotherapy Sales Share by Application (2021-2032) Figure 62. Asia Radiotherapy Revenue Share by Type (2021-2032) Figure 63. Asia Radiotherapy Sales Share by Type (2021-2032) Figure 64. Asia Radiotherapy Revenue Share by Application (2021-2032) Figure 65. Asia Radiotherapy Sales Share by Application (2021-2032) Figure 66. Asia Radiotherapy Revenue Share by Country (2021-2032) Figure 67. Asia Radiotherapy Sales Share by Country (2021-2032) Figure 68. SAMEA Radiotherapy Revenue Share by Type (2021-2032) Figure 69. SAMEA Radiotherapy Sales Share by Type (2021-2032) Figure 70. SAMEA Radiotherapy Revenue Share by Application (2021-2032) Figure 71. SAMEA Radiotherapy Sales Share by Application (2021-2032) Figure 72. SAMEA Radiotherapy Revenue Share by Country (2021-2032) Figure 73. SAMEA Radiotherapy Sales Share by Country (2021-2032) Figure 74. Radiotherapy Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Radiotherapy Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • External Beam Radiotherapy
  • Internal Beam Radiotherapy
Applications
  • Lung Cancer
  • Breast Cancer
  • Rectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Liver Cancer
  • Cervical Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Other
Companies covered
  • Varian Medical Systems (Siemens Healthineers)
  • Elekta
  • Hitachi
  • IBA(Ion Beam Applications S.A)
  • Accuray
  • Mevion Medical Systems
  • Shanghai United Imaging Healthcare
  • Shinva Medical Instrument
  • Toshiba
  • Neusoft Medical Systems
  • Chengdu Linike Medical
  • Sumitomo Heavy Industries
  • Jiangsu Haiming Medical Equipment
  • SinoPower Accelerator

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiotherapy Market by Type
  3. 1.2.1 Global Radiotherapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 External Beam Radiotherapy
  5. 1.2.3 Internal Beam Radiotherapy
  6. 1.3 Radiotherapy Market by Application
  7. 1.3.1 Global Radiotherapy Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Lung Cancer
  9. 1.3.3 Breast Cancer
  10. 1.3.4 Rectal Cancer
  11. 1.3.5 Prostate Cancer
  12. 1.3.6 Stomach Cancer
  13. 1.3.7 Liver Cancer
  14. 1.3.8 Cervical Cancer
  15. 1.3.9 Lung Cancer
  16. 1.3.10 Head and Neck Cancer
  17. 1.3.11 Other
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Radiotherapy Market Dynamics
  1. 2.1 Radiotherapy Industry Trends
  2. 2.2 Radiotherapy Industry Drivers
  3. 2.3 Radiotherapy Industry Opportunities and Challenges
  4. 2.4 Radiotherapy Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Radiotherapy Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Radiotherapy Revenue by Region
  3. 3.2.1 Global Radiotherapy Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiotherapy Revenue by Region (2021-2026)
  5. 3.2.3 Global Radiotherapy Revenue by Region (2027-2032)
  6. 3.2.4 Global Radiotherapy Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Radiotherapy Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Radiotherapy Sales by Region
  9. 3.4.1 Global Radiotherapy Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Radiotherapy Sales by Region (2021-2026)
  11. 3.4.3 Global Radiotherapy Sales by Region (2027-2032)
  12. 3.4.4 Global Radiotherapy Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Radiotherapy Revenue by Manufacturers
  2. 4.1.1 Global Radiotherapy Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Radiotherapy Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Radiotherapy Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiotherapy Sales by Manufacturers
  6. 4.2.1 Global Radiotherapy Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Radiotherapy Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Radiotherapy Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Radiotherapy Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Radiotherapy Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Radiotherapy Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Radiotherapy Manufacturers, Product Type & Application
  13. 4.7 Global Radiotherapy Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Radiotherapy Market CR5 and HHI
  16. 4.8.2 2025 Radiotherapy Tier 1, Tier 2, and Tier 3
5 Radiotherapy Market by Type
  1. 5.1 Global Radiotherapy Revenue by Type
  2. 5.1.1 Global Radiotherapy Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Radiotherapy Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Radiotherapy Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Radiotherapy Sales by Type
  6. 5.2.1 Global Radiotherapy Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiotherapy Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Radiotherapy Sales Market Share by Type (2021-2032)
  9. 5.3 Global Radiotherapy Price by Type
6 Radiotherapy Market by Application
  1. 6.1 Global Radiotherapy Revenue by Application
  2. 6.1.1 Global Radiotherapy Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Radiotherapy Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Radiotherapy Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Radiotherapy Sales by Application
  6. 6.2.1 Global Radiotherapy Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Radiotherapy Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Radiotherapy Sales Market Share by Application (2021-2032)
  9. 6.3 Global Radiotherapy Price by Application
7 Company Profiles
  1. 7.1 Varian Medical Systems (Siemens Healthineers)
  2. 7.1.1 Varian Medical Systems (Siemens Healthineers) Company Information
  3. 7.1.2 Varian Medical Systems (Siemens Healthineers) Business Overview
  4. 7.1.3 Varian Medical Systems (Siemens Healthineers) Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Varian Medical Systems (Siemens Healthineers) Radiotherapy Product Portfolio
  6. 7.1.5 Varian Medical Systems (Siemens Healthineers) Recent Developments
  7. 7.2 Elekta
  8. 7.2.1 Elekta Company Information
  9. 7.2.2 Elekta Business Overview
  10. 7.2.3 Elekta Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Elekta Radiotherapy Product Portfolio
  12. 7.2.5 Elekta Recent Developments
  13. 7.3 Hitachi
  14. 7.3.1 Hitachi Company Information
  15. 7.3.2 Hitachi Business Overview
  16. 7.3.3 Hitachi Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hitachi Radiotherapy Product Portfolio
  18. 7.3.5 Hitachi Recent Developments
  19. 7.4 IBA(Ion Beam Applications S.A)
  20. 7.4.1 IBA(Ion Beam Applications S.A) Company Information
  21. 7.4.2 IBA(Ion Beam Applications S.A) Business Overview
  22. 7.4.3 IBA(Ion Beam Applications S.A) Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 IBA(Ion Beam Applications S.A) Radiotherapy Product Portfolio
  24. 7.4.5 IBA(Ion Beam Applications S.A) Recent Developments
  25. 7.5 Accuray
  26. 7.5.1 Accuray Company Information
  27. 7.5.2 Accuray Business Overview
  28. 7.5.3 Accuray Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Accuray Radiotherapy Product Portfolio
  30. 7.5.5 Accuray Recent Developments
  31. 7.6 Mevion Medical Systems
  32. 7.6.1 Mevion Medical Systems Company Information
  33. 7.6.2 Mevion Medical Systems Business Overview
  34. 7.6.3 Mevion Medical Systems Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mevion Medical Systems Radiotherapy Product Portfolio
  36. 7.6.5 Mevion Medical Systems Recent Developments
  37. 7.7 Shanghai United Imaging Healthcare
  38. 7.7.1 Shanghai United Imaging Healthcare Company Information
  39. 7.7.2 Shanghai United Imaging Healthcare Business Overview
  40. 7.7.3 Shanghai United Imaging Healthcare Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai United Imaging Healthcare Radiotherapy Product Portfolio
  42. 7.7.5 Shanghai United Imaging Healthcare Recent Developments
  43. 7.8 Shinva Medical Instrument
  44. 7.8.1 Shinva Medical Instrument Company Information
  45. 7.8.2 Shinva Medical Instrument Business Overview
  46. 7.8.3 Shinva Medical Instrument Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shinva Medical Instrument Radiotherapy Product Portfolio
  48. 7.8.5 Shinva Medical Instrument Recent Developments
  49. 7.9 Toshiba
  50. 7.9.1 Toshiba Company Information
  51. 7.9.2 Toshiba Business Overview
  52. 7.9.3 Toshiba Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Toshiba Radiotherapy Product Portfolio
  54. 7.9.5 Toshiba Recent Developments
  55. 7.10 Neusoft Medical Systems
  56. 7.10.1 Neusoft Medical Systems Company Information
  57. 7.10.2 Neusoft Medical Systems Business Overview
  58. 7.10.3 Neusoft Medical Systems Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Neusoft Medical Systems Radiotherapy Product Portfolio
  60. 7.10.5 Neusoft Medical Systems Recent Developments
  61. 7.11 Chengdu Linike Medical
  62. 7.11.1 Chengdu Linike Medical Company Information
  63. 7.11.2 Chengdu Linike Medical Business Overview
  64. 7.11.3 Chengdu Linike Medical Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Chengdu Linike Medical Radiotherapy Product Portfolio
  66. 7.11.5 Chengdu Linike Medical Recent Developments
  67. 7.12 Sumitomo Heavy Industries
  68. 7.12.1 Sumitomo Heavy Industries Company Information
  69. 7.12.2 Sumitomo Heavy Industries Business Overview
  70. 7.12.3 Sumitomo Heavy Industries Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sumitomo Heavy Industries Radiotherapy Product Portfolio
  72. 7.12.5 Sumitomo Heavy Industries Recent Developments
  73. 7.13 Jiangsu Haiming Medical Equipment
  74. 7.13.1 Jiangsu Haiming Medical Equipment Company Information
  75. 7.13.2 Jiangsu Haiming Medical Equipment Business Overview
  76. 7.13.3 Jiangsu Haiming Medical Equipment Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jiangsu Haiming Medical Equipment Radiotherapy Product Portfolio
  78. 7.13.5 Jiangsu Haiming Medical Equipment Recent Developments
  79. 7.14 SinoPower Accelerator
  80. 7.14.1 SinoPower Accelerator Company Information
  81. 7.14.2 SinoPower Accelerator Business Overview
  82. 7.14.3 SinoPower Accelerator Radiotherapy Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 SinoPower Accelerator Radiotherapy Product Portfolio
  84. 7.14.5 SinoPower Accelerator Recent Developments
8 North America
  1. 8.1 North America Radiotherapy Market Size by Type
  2. 8.1.1 North America Radiotherapy Revenue by Type (2021-2032)
  3. 8.1.2 North America Radiotherapy Sales by Type (2021-2032)
  4. 8.1.3 North America Radiotherapy Price by Type (2021-2032)
  5. 8.2 North America Radiotherapy Market Size by Application
  6. 8.2.1 North America Radiotherapy Revenue by Application (2021-2032)
  7. 8.2.2 North America Radiotherapy Sales by Application (2021-2032)
  8. 8.2.3 North America Radiotherapy Price by Application (2021-2032)
  9. 8.3 North America Radiotherapy Market Size by Country
  10. 8.3.1 North America Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Radiotherapy Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Radiotherapy Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Radiotherapy Market Size by Type
  2. 9.1.1 Europe Radiotherapy Revenue by Type (2021-2032)
  3. 9.1.2 Europe Radiotherapy Sales by Type (2021-2032)
  4. 9.1.3 Europe Radiotherapy Price by Type (2021-2032)
  5. 9.2 Europe Radiotherapy Market Size by Application
  6. 9.2.1 Europe Radiotherapy Revenue by Application (2021-2032)
  7. 9.2.2 Europe Radiotherapy Sales by Application (2021-2032)
  8. 9.2.3 Europe Radiotherapy Price by Application (2021-2032)
  9. 9.3 Europe Radiotherapy Market Size by Country
  10. 9.3.1 Europe Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Radiotherapy Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Radiotherapy Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Radiotherapy Market Size by Type
  2. 10.1.1 China Radiotherapy Revenue by Type (2021-2032)
  3. 10.1.2 China Radiotherapy Sales by Type (2021-2032)
  4. 10.1.3 China Radiotherapy Price by Type (2021-2032)
  5. 10.2 China Radiotherapy Market Size by Application
  6. 10.2.1 China Radiotherapy Revenue by Application (2021-2032)
  7. 10.2.2 China Radiotherapy Sales by Application (2021-2032)
  8. 10.2.3 China Radiotherapy Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiotherapy Market Size by Type
  2. 11.1.1 Asia Radiotherapy Revenue by Type (2021-2032)
  3. 11.1.2 Asia Radiotherapy Sales by Type (2021-2032)
  4. 11.1.3 Asia Radiotherapy Price by Type (2021-2032)
  5. 11.2 Asia Radiotherapy Market Size by Application
  6. 11.2.1 Asia Radiotherapy Revenue by Application (2021-2032)
  7. 11.2.2 Asia Radiotherapy Sales by Application (2021-2032)
  8. 11.2.3 Asia Radiotherapy Price by Application (2021-2032)
  9. 11.3 Asia Radiotherapy Market Size by Country
  10. 11.3.1 Asia Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Radiotherapy Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Radiotherapy Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiotherapy Market Size by Type
  2. 12.1.1 SAMEA Radiotherapy Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Radiotherapy Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Radiotherapy Price by Type (2021-2032)
  5. 12.2 SAMEA Radiotherapy Market Size by Application
  6. 12.2.1 SAMEA Radiotherapy Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Radiotherapy Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Radiotherapy Price by Application (2021-2032)
  9. 12.3 SAMEA Radiotherapy Market Size by Country
  10. 12.3.1 SAMEA Radiotherapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Radiotherapy Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Radiotherapy Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Radiotherapy Value Chain Analysis
  2. 13.1.1 Radiotherapy Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Radiotherapy Production Mode & Process
  6. 13.2 Radiotherapy Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Radiotherapy Distributors
  9. 13.2.3 Radiotherapy Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst